Ekf Diagnostics Regulatory News (EKF)

EKF DIAGNOSTICS HOLDINGS PLC

("EKF" or the "Company")

Issue of Equity and Total Voting Rights

EKF Diagnostics Holdings plc (AIM: EKF) announces that it has allotted 12,688,542 new ordinary shares of 1 pence each in the Company (the "New Ordinary Shares") to Mr Berthold Walter.

The allotment of the New Ordinary Shares was pursuant to the terms of the Purchase and Assignment of Business Shares agreement, dated 15 June 2010, (the "Transaction Agreement") entered into between the Company and Mr Walter, among others, when the Company acquired EKF Diagnostics GmbH. The 12,688,542 shares form the majority of the deferred consideration held back by the Company to secure the Company's right to indemnification under the Transaction Agreement.

Application has been made for the 12,688,542 New Ordinary Shares, which will rank pari passu with all existing Ordinary Shares, to be admitted to trading on AIM. Dealings in the new Ordinary Shares are expected to commence on 15 November 2012.

Following the allotment of New Ordinary Shares and Admission, Mr Berthold will hold 12,688,542 Ordinary Shares in EKF representing 4.76 per cent. of the issued share capital of the Company.

Total Voting Rights

Following admission of the New Ordinary Shares, there will be 266,567,652 Ordinary Shares in issue, each carrying one vote per Ordinary Share. The Company does not hold any Ordinary Shares in treasury. The total number of voting rights in the Company's Ordinary Shares will be 266,567,652 and this number may be used by shareholders as the denominator in calculations to determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Services Authority's Disclosure and Transparency Rules.

Enquiries: